NCT04829903View on ClinicalTrials.gov

Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin

NACompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

January 2, 2020

Primary Completion Date

March 29, 2021

Study Completion Date

November 20, 2021

Conditions
Type 2 Diabetes Treated With InsulinObesityAdolescent Obesity
Interventions
DRUG

Dulaglutide

Dulaglutide injections

DRUG

Liraglutide

Liraglutide injections

Trial Locations (1)

Unknown

Zainab Khan, Lahore

Sponsors
All Listed Sponsors
lead

Corporacion Parc Tauli

OTHER

NCT04829903 - Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin | Biotech Hunter | Biotech Hunter